Catalyst Pharmaceuticals, Inc. · NASDAQ:CPRX
Andrews William T. exercised options for 3,052 Catalyst Pharmaceuticals, Inc. shares (Form 4)
Traded Jun 3, 2026 · Filed Jun 5, 2026
On Jun 3, 2026, Andrews William T. (Chief Medical Officer) exercised options for 3,052 Catalyst Pharmaceuticals, Inc. shares, leaving 2,309 shares. Filed Jun 5, 2026 (Form 4).
- Options exercised
- 3,052 shares
- Holding after
- 2,309 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 3, 2026 | Common Stock, par value $0.001 per share | Option exercise | 3,052 | 3,052 | Direct | |
| Jun 3, 2026 | Common Stock, par value $0.001 per share | Shares withheld for tax | 743 | 2,309 | Direct |
Source
Related
- Catalyst Pharmaceuticals, Inc.
- Andrews William T.
- Catalyst Pharmaceuticals, Inc. shareholders
- Form 4 · Andrews William T. · Jul 17, 2026
- Form 4 · McEnany Patrick J · Jul 17, 2026
- Form 4 · Del Carmen Jeffrey · Jul 17, 2026
- Form 4 · Russo Gregg · Jul 17, 2026
- Form 4 · Daly Richard J · Jul 17, 2026
- Form 4 · Denkhaus Donald A · Jul 17, 2026